ImportantCompany Update

BASF India has published its financial results for the quarter.

Fredun Pharmaceuticals Ltd539730 · Filed with the exchange

The company reported a consolidated total income of ₹482.43 Cr, marking an increase from ₹374.13 Cr in the prior-year quarter.

Consolidated net profit after tax surged to ₹36.03 Cr, significantly higher than ₹13.74 Cr year-over-year.

Earnings per share (EPS) also rose to ₹83.3 from ₹31.7, indicating robust financial performance and strong growth across operations.

This update highlights strong top-line growth and enhanced profitability for the company, reflecting a positive operational period.

Read the original filing(PDF)

No comments yet. Be the first.

More from Fredun Pharmaceuticals Ltd

All announcements